Immunodiagnostics Market Size, Share and Industry Analysis By Product Instruments, Reagents & Consumables), By Application (Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases), By End user (Clinical Laboratories, Hospitals, Physician’s Offices), By End-user(Hospitals, Dental Clinics, Academic & Research Institutes) and Regional Forecast, 2026- 2034
Download Free Sample To get information on various segments, share your queries with us
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2021-2034 |
|
Base Year |
2025 |
|
Estimated Year |
2026 |
|
Forecast Period |
2026-2034 |
|
Historical Period |
2021-2024 |
|
Unit |
Value (USD Billion) |
|
Growth Rate |
CAGR of 7.58% from 2026 to 2034 |
|
By Product |
· Instruments · Reagents & Consumables |
|
By Application |
· Oncology & Endocrinology · Hepatitis & Retrovirus · Cardiac Markers · Infectious Diseases · Others |
|
By End user
|
· Clinical Laboratories · Hospitals · Physician’s Offices · Others |
|
By Geography |
· North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) |
Key Industry Developments
- In March 2019, Oncimmune announced the acquisition of Protagen Diagnostics.
- In November 2018, Ortho Clinical Diagnostics received U.S FDA approval for the company’s VITROS HIV Combo test, an immunodiagnostic detect HIV-1 and HIV-2 antibodies (Ab) and the p24 antigen (Ag).
- In May 2016, Diasorin announced the acquisition of Quest Diagnostics’ immunodiagnostics products.
- 2021-2034
- 2025
- 2021-2024
- 137
.webp){kind=small}
Related Reports
-
US +1 833 909 2966 ( Toll Free )
-
Get In Touch With Us